Susana M. Yuste-Romero

Pontevedra, GA 36161, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

The Effectiveness of Janus Kinase Inhibitors for the Management of Relapsing Takayasu Arteritis: A Spanish Real-World Study and Comprehensive Review of the Literature.

The Effectiveness of Janus Kinase Inhibitors for the Management of Relapsing Takayasu Arteritis: A Spanish Real-World Study and Comprehensive Review of the Literature.

Journal: Life (Basel, Switzerland)

Published: May 14, 2026

Filgotinib in Moderate to Severe Rheumatoid Arthritis in a Real-World Setting: Up to 6-Month Effectiveness, Patient-Reported Outcomes, and Persistence, and up to 24-Month Safety from More than 1400 Patients in the FILOSOPHY and PARROTFISH Studies.

Filgotinib in Moderate to Severe Rheumatoid Arthritis in a Real-World Setting: Up to 6-Month Effectiveness, Patient-Reported Outcomes, and Persistence, and up to 24-Month Safety from More than 1400 Patients in the FILOSOPHY and PARROTFISH Studies.

Journal: Rheumatology and therapy

Published: April 29, 2026

Navigating the gap: the challenge of applying treat-to-target in routine lupus care-a national perspective.

Navigating the gap: the challenge of applying treat-to-target in routine lupus care-a national perspective.

Journal: Lupus science & medicine

Published: January 26, 2026

Extracranial subcutaneous nodules in giant cell arteritis: response to baricitinib.

Extracranial subcutaneous nodules in giant cell arteritis: response to baricitinib.

Journal: Clinical and experimental rheumatology

Published: January 03, 2026

What to do when the first TNF inhibitor fails in rheumatoid arthritis: stratified expert recommendations from a scoping review and Delphi consensus.

What to do when the first TNF inhibitor fails in rheumatoid arthritis: stratified expert recommendations from a scoping review and Delphi consensus.

Journal: Therapeutic advances in musculoskeletal disease

Published: October 08, 2025

SUBCUTANEOUS VERSUS INTRAVENOUS TOCILIZUMAB IN AORTITIS ASSOCIATED WITH GIANT CELL ARTERITIS: MULTICENTER STUDY OF 196 PATIENTS.

SUBCUTANEOUS VERSUS INTRAVENOUS TOCILIZUMAB IN AORTITIS ASSOCIATED WITH GIANT CELL ARTERITIS: MULTICENTER STUDY OF 196 PATIENTS.

Journal: Arthritis care & research

Published: August 26, 2025

Subcutaneous Versus Intravenous Tocilizumab in Aortitis Associated With Giant Cell Arteritis: Multicenter Study of 196 Patients.

Subcutaneous Versus Intravenous Tocilizumab in Aortitis Associated With Giant Cell Arteritis: Multicenter Study of 196 Patients.

Journal: Arthritis care & research

Published: August 26, 2025

RESER/NVAN: Spanish Registry of patients with ANCA- associated vasculitis: objectives and methodology.

RESER/NVAN: Spanish Registry of patients with ANCA- associated vasculitis: objectives and methodology.

Journal: Reumatologia clinica

Published: July 24, 2025

Lingual necrosis in giant-cell arteritis: a case-based review.

Lingual necrosis in giant-cell arteritis: a case-based review.

Journal: Rheumatology international

Published: May 23, 2025

Tocilizumab in cranial and extracranial giant cell arteritis: a national multicentre study of 471 cases.

Tocilizumab in cranial and extracranial giant cell arteritis: a national multicentre study of 471 cases.

Journal: Rheumatology (Oxford, England)

Published: August 29, 2024

Recommendations for the diagnosis and treatment of anti-neutrophil cytoplasmic autoantibody associated vasculitis.

Recommendations for the diagnosis and treatment of anti-neutrophil cytoplasmic autoantibody associated vasculitis.

Journal: Nefrologia

Published: July 15, 2024

Integrating different perspectives to define a concept of comprehensive remission in rheumatoid arthritis: The SUMAR project.

Integrating different perspectives to define a concept of comprehensive remission in rheumatoid arthritis: The SUMAR project.

Journal: Reumatologia clinica

Published: June 05, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026